Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery

Mycoses

Volumn 46, Issue 5-6, 2003, Pages 233-236

  Gosbell, Iain B ^a,b   Toumasatos, V ^a   Yong, J ^a,b   Kuo, R S ^c   Ellis, D H ^d   Perrie, R C ^d  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Antimycotic chemotherapy; Scedosporium prolificans; Synergy; Terbinafine; Voriconazole

Indexed keywords

ITRACONAZOLE; TERBINAFINE; VORICONAZOLE;

AGED; AMPUTATION; ANTIBIOTIC RESISTANCE; ARTICLE; BONE INFECTION; CASE REPORT; DEBRIDEMENT; DRUG POTENTIATION; HUMAN; IMMUNE DEFICIENCY; LUNG INFECTION; MALE; OOMYCETES; ORBIT CELLULITIS; PRIORITY JOURNAL; PYTHIUM INSIDIOSUM; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; TREATMENT OUTCOME;

AGED; ANKLE INJURIES; ANTIFUNGAL AGENTS; DEBRIDEMENT; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MADUROMYCOSIS; MALE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; PYRIMIDINES; SCEDOSPORIUM; TRIAZOLES;

OOMYCETES; PYTHIUM; PYTHIUM INSIDIOSUM; SCEDOSPORIUM PROLIFICANS;

EID: 0037715151     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2003.00878.x     Document Type: Article

References (18)

1. Malloch D, Salkin IF. A new species of Scedosporium associated with osteomyelitis in humans. Mycotaxon 1984; 21: 247-55.
2. Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia 1989; 106: 13-22.
3. Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027-33.
4. Toy EC, Rinaldi MG, Savitch CB, Leibovitch ER. Endocarditis and hip arthritis associated with Scedosporium inflatum. South Med J 1990: 83: 957-60.
5. Wilson CM, O'Rourke EJ, McGinnis MR, Salkin IF. Scedosporium inflatum: clinical spectrum of a newly recognized pathogen. J Infect Dis 1990; 161: 102-7.
6. Gosbell IB, Morris ML, Gallo JH, et al. Clinical, pathological, and epidemiological features of infection with Scedosporium prolificans: four cases and review. Clin Microbiol Infect 1999; 5: 672-86.
7. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrobial Agents Chemother 1997; 41: 841-3.
8. Johnson EM, Szekely A, Warnock DW. In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens. Antimicrobial Agents Chemother 1999; 43: 1260-63.
9. Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrobial Chemother 1999; 43: 149-51.
10. Del Poeta M, Schell WA, Perfect JR. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrobial Agents Chemother 1997; 41: 1835-6.
11. Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi, MG, Pizzo PA. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrobial Agents Chemother 1995; 39: 1361-4.
12. Meletiadis J, Mouton JW, Rodriguez-Tudela JL, Meis JF, Verweij PE. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrobial Agents Chemother 2000: 44: 470-72.
13. Verweij PE, Cox NJ, Meis JF. Oral terbinafine for treatment of pulmonary Pseudallescheria boydii infection refractory to itraconazole therapy [letter]. Eur J Clin Microbiol Infect Dis 1997; 16: 26-8.
14. Shenep JL, English BK, Kaufman L, et al. Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child. Clin Infect Dis 1998; 27: 1388-93.
15. Anonymous. NCCLS. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi; Proposed Standard. NCCLS document M38-P.NCCLS, Pennsylvania, 1998.
16. Hinder J. Clin. Microbiol. Procedures Handbook, Vol 1. Washington DC, USA: ASM, 1992.
17. Perrie R, Ellis D. Synergy of terbinafine and voriconazole against Scedosporium prolificans. Antimicrobials 2001. Australian Society for Antimicrobials 2nd Annual Scientific Meeting, Melbourne, April 2001. Ref Type: Abstract, 2001.
18. Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. [Review] [159 refs]. Clin Microbiol Rev 1999; 12: 501-17.